Berlin-based Vara raises €6.5 million for AI-powered breast cancer screening software
Summary
Today Vara, the Berlin-based company on a mission to save lives by making breast cancer screening accessible worldwide, has raised a €6.5 million Series A funding round, led by OMERS Ventures. Potentially suspicious mammograms can be viewed through Vara’s highly optimised workflow software, which has been purposefully designed to cater to radiologists’ specific requirements and has enabled early customers to significantly speed up their reporting process. Trained and tested on one of the world’s largest breast cancer datasets of 2.5 million images, Vara is a highly accurate algorithmic safety net that augments human capabilities. Vara CEO and co-founder Jonas Muff comments: “It is our mission to broaden access to breast cancer screening, with too many women around the world not able to receive critical examinations. This results in fewer lives lost, and by streamlining the whole process, from detection to report-filing, even more women can get access to critical screenings.” OMERS Ventures Associate Director Bryony Marshall adds: “Vara has developed a truly pioneering platform that can significantly improve the outcome for breast cancer patients, and reinforces the value that AI can bring to the health sector.
Funding
Review available funding amount, funding date, investors, and linked company information related to Berlin-based Vara raises €6.5 million for AI-powered breast cancer screening software in the interactive ISVWorld profile.